Patents Assigned to DegenRx B.V.
  • Amyloid beta oligomer specific binding molecule
    Patent number: 11104725
    Abstract: This disclosure relates to an amyloid beta peptide (A?)-oligomer-specific antigen binding molecule and the use thereof as a diagnostic agent or as a therapeutic agent for the treatment or prevention of Alzheimer's Disease, Down's syndrome, mild cognitive impairment, cerebral amyloid angiopathy, vascular dementia, multi-infarct dementia, Parkinson's disease, Dementia with Lewy Bodies, Huntington's disease, Creutzfeldt-Jakob disease, cystic fibrosis, or Gaucher's disease.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: August 31, 2021
    Assignee: DegenRx B.V.
    Inventors: Samantha Kathleen Cobb, Michael Foley, Augustinus Petrus Henricus Scheefhals, Armand Wilbrandt Jannes Wichert Tepper